NEA Management Company, LLC Portfolio

Auto-discovered 13F filer (Top-2000 by latest reported value).

SEC 13F CIK: 0001512848

What is a 13F filing? Who files one and when · What 13F filings can't tell you

MidFocusedHealth Tilt how tags are computed

Q2 2026 · 26 positions · Total reported value $1.59B · Top-10 concentration 89.8% · Updated 2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

Turnover: 14.8% · 1 new · 2 cut · 1 exited

Active Share (vs S&P 500): 100.0% · vs QQQ: 100.0% — share of the book that differs from index weights (higher = more active) · ranking

Est. Qtr Return (Q1 2026 → Q2 2026): +16.5% · vs SPY +1.7% · Prev Value $1.76B — last quarter positions weighted by this quarter price moves · ranking

In its Q2 2026 13F filing, NEA Management Company, LLC disclosed 26 equity positions with a combined reported value of $1.59B. The filing implies a focused portfolio: its ten largest positions account for 89.8% of reported value. HoldingsHub classifies the profile as Mid / Focused / Health Tilt.

The largest disclosed positions as of Q2 2026 were TRVI ($246.59M), MBX ($199.52M), GLUE ($186.15M). By sector, the heaviest allocations are Health Care 95.4%, Technology 4.6%. Versus the prior quarter, allocation shifted toward Health Care (+19.6pp) and away from Other (-19.9pp).

Versus the prior quarter, NEA Management Company, LLC opened 1 new positions, trimmed 2 and fully exited 1, a turnover rate of 14.8% of positions. The portfolio's overlap with the prior quarter was 93% of names.

The largest new positions opened in Q2 2026 were KPTI ($5.64M).

Of the 1 positions fully exited versus the prior quarter, the largest were ACLX ($349.66M).

Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.

New Positions (Q2 2026)

  • KPTI KARYOPHARM THERAPEUTICS INC · $5.64M

Fully Exited (vs previous quarter)

  • ACLX ARCELLX INC · prev qtr: $349.66M

Insider Transactions (Form 4)

Latest NEA Management Company, LLC buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.

No Form 4 filings for this fund yet — when its ownership in a stock crosses 10%, buys and sells are filed here within two business days.

Fund Profile

NEA Management Company, LLC is an investment management firm based in Menlo Park, California, with approximately $35.6 billion in assets under management. The firm discloses its U.S. equity portfolio through SEC 13F filings.

Investment Approach

As a registered investment advisor, NEA Management Company, LLC discloses its holdings of U.S. publicly traded stocks through SEC 13F filings. The firm's investment strategy focuses on equity markets.

Asset Classes

The firm's portfolio primarily consists of U.S. publicly traded stocks, with equity positions regularly disclosed through SEC 13F filings.

Key Information

  • Headquartered in Menlo Park, California
  • Approximately $35.6 billion in assets under management according to SEC Form ADV
  • Operates as a registered investment advisor
  • Discloses equity investments through SEC 13F filings

For official disclosures about NEA Management Company, LLC, please refer to SEC filings.

AI Rebalance Analysis

1. Overall Direction and Market View: The NEA Management Company, LLC fund maintained a conservative stance in the second quarter of 2026, with a slight preference for Health Care sector investments, suggesting a cautious approach amidst market uncertainty. 2. Key Moves: - Added: The fund initiated a new position, indicating a new investment opportunity was identified. - Reduced: Celularity Inc. (CELC) was reduced by 25.2% in shares, reflecting a possible reevaluation of its prospects or a shift in strategy. - No Change: The fund held positions steady in the Health Care sector, with no significant changes in shareholdings for the other companies. 3. Portfolio Structure: - Passive/Active: The portfolio appears to be more passive, with a low turnover rate and no significant changes in shareholdings. - Sector Bias: The fund has a strong bias towards the Health Care sector, with 75.4% of its total value invested in it. - Risk Appetite: The risk appetite seems moderate, with a focus on stability rather than aggressive growth. 4. Per-Holding One-Liner: - TRVI: Trevena, Inc. - develops novel therapies for the treatment of chronic pain. - MBX: MBX Biociences, Inc. - a biotechnology company focused on developing therapies for rare genetic disorders. - GLUE: Monte Rosa Therapeutics - a biopharmaceutical company focused on developing treatments for cardiovascular diseases. - CELC: Celularity, Inc. - a biotechnology company focused on developing therapies for cancer and other diseases. - SGP: Spyglass Pharma, Inc. - a biopharmaceutical company focused on developing novel treatments for infectious diseases. - SVRA: Savara, Inc. - a biopharmaceutical company focused on developing treatments for respiratory diseases. - ZBIO: Zenas Biopharma, Inc. - a biopharmaceutical company focused on developing therapies for cancer. - COUR: Coursera, Inc. - an online learning platform offering courses, specializations, and degrees. - AUPH: Aurobindo Pharma, Ltd. - a pharmaceutical company engaged in the research, development, and manufacture of pharmaceutical products. - CRSP: Crispr Therapeutics AG - a biotechnology company focused on developing CRISPR/Cas9-based gene-editing technologies. 5. One-Sentence Style Summary: The NEA Management Company, LLC fund maintained a conservative and sector-focused approach, adding a new position while holding steady on its Health Care investments, reflecting a cautious yet strategic market stance.

Generated by GLM-4.5-flash from the latest 13F holdings and quarter-over-quarter changes. For reference only, not investment advice.

Sector Allocation

Health Care 95.4%
Technology 4.6%
Sort by: Value Shares Weight Sector Change · CSV
# Shares Value Weight Allocation Change
1 13.22M $246.59M 15.53%
15.53%
Hold
2 3.61M $199.52M 12.56%
12.56%
Hold
3 7.69M $186.15M 11.72%
11.72%
Hold
4 1.71M $178.96M 11.27%
11.27%
Reduce
5 7.39M $164.55M 10.36%
10.36%
Hold
6 24.47M $150.74M 9.49%
9.49%
Hold
7 4.02M $102.11M 6.43%
6.43%
Hold
8 12.87M $72.57M 4.57%
4.57%
Hold
9 3.97M $67.37M 4.24%
4.24%
Hold
10 1.06M $57.73M 3.64%
3.64%
Hold
11 4.12M $44.60M 2.81%
2.81%
Hold
12 1.96M $21.27M 1.34%
1.34%
Hold
13 1.30M $17.11M 1.08%
1.08%
Hold
14 3.23M $15.10M 0.95%
0.95%
Hold
15 1.71M $10.56M 0.67%
0.67%
Hold
16 3.57M $10.10M 0.64%
0.64%
Hold
17 1.95M $10.05M 0.63%
0.63%
Reduce
18 4.45M $8.23M 0.52%
0.52%
Hold
19 576.78K $5.64M 0.35%
0.35%
New
20 1.46M $5.53M 0.35%
0.35%
Hold
21 464.40K $4.27M 0.27%
0.27%
Hold
22 3.78M $4.15M 0.26%
0.26%
Hold
23 1.63M $2.39M 0.15%
0.15%
Hold
24 478.55K $2.18M 0.14%
0.14%
Hold
25 50.01K $295.03K 0.02%
0.02%
Hold
26 1.00M $164.60K 0.01%
0.01%
Hold

Holdings Prediction Model

Predicts next-quarter Top-10 holdings and weights from the fund's own historical trading轨迹 (add / reduce / hold) plus each stock's price momentum and relative volume. Strictly no look-ahead: a prediction for quarter T+1 uses only data through quarter T. Weights are shares of the modelled portfolio.

The next-quarter predicted Top 10 (2026-Q3) is shown in the «Latest Q · Forecast» tab above, in the same holdings format. That view is for logged-in accounts: 3 views per day on Free, unlimited on Gold/Diamond.

Latest-Quarter Accuracy (2026-Q2)

P 90% R 90% F1 90% (modelled on 2026-Q1; 9/10 hit)

Historical Backtest (10 quarters)

Avg precision 84% · recall 84% · F1 84% · avg rank error 1.9 · Top-10 turnover 16%

Quarter Prec. Recall F1 Predicted Top 10 Actual Top 10
2024-Q1 90% 90% 90% COUR · ACLX · RYTM · SVRA · VRNA · CRSP · CVRX · GERN · GLUE · KRRO ACLX · CRSP · RYTM · SVRA · COUR · KRRO · VRNA · GLUE · NN · CVRX
2024-Q2 80% 80% 80% ACLX · CRSP · RYTM · SVRA · COUR · KRRO · VRNA · GLUE · NN · CVRX ACLX · TEM · RYTM · SVRA · COUR · CRSP · VRNA · NN · KRRO · TRVI
2024-Q3 80% 80% 80% ACLX · TEM · RYTM · SVRA · COUR · CRSP · VRNA · NN · KRRO · TRVI ACLX · TEM · VRNA · RYTM · SVRA · COUR · MBX · CRSP · NN · ZBIO
2024-Q4 90% 90% 90% TEM · ACLX · VRNA · RYTM · SVRA · COUR · MBX · CRSP · NN · ZBIO ACLX · VRNA · TEM · RYTM · NN · COUR · SVRA · MBX · CRSP · GLUE
2025-Q1 80% 80% 80% ACLX · VRNA · TEM · RYTM · NN · COUR · SVRA · MBX · CRSP · GLUE ACLX · VRNA · RYTM · TEM · COUR · TRVI · SVRA · CRSP · GLUE · AUPH
2025-Q2 80% 80% 80% ACLX · VRNA · RYTM · TEM · COUR · TRVI · SVRA · CRSP · GLUE · AUPH ACLX · VRNA · RYTM · COUR · CRSP · TRVI · SVRA · ORIC · MBX · GLUE
2025-Q3 80% 80% 80% ACLX · VRNA · RYTM · COUR · CRSP · TRVI · SVRA · ORIC · MBX · GLUE RYTM · ACLX · VRNA · COUR · TRVI · CELC · SVRA · CRSP · MBX · ZBIO
2025-Q4 80% 80% 80% RYTM · ACLX · VRNA · COUR · TRVI · CELC · SVRA · CRSP · MBX · ZBIO CELC · RYTM · ACLX · TRVI · SVRA · ZBIO · GLUE · MBX · COUR · AUPH
2026-Q1 90% 90% 90% CELC · RYTM · ACLX · TRVI · SVRA · ZBIO · GLUE · MBX · COUR · AUPH ACLX · CELC · SGP · TRVI · SVRA · GLUE · MBX · ZBIO · COUR · AUPH
2026-Q2 ★ 90% 90% 90% ACLX · CELC · SGP · TRVI · SVRA · GLUE · MBX · ZBIO · COUR · AUPH TRVI · MBX · GLUE · CELC · SGP · SVRA · ZBIO · COUR · AUPH · CRSP

★ = latest filed quarter (predicted vs actual). Recall = share of the real Top 10 caught by the model; precision = share of the predicted Top 10 that were real.

FAQ

What did NEA Management Company, LLC buy in 2026-Q2?

In its 2026-Q2 13F filing, NEA Management Company, LLC reported 26 equity positions worth $1.59B in aggregate; its largest disclosed positions were TRVI ($246.59M), MBX ($199.52M), GLUE ($186.15M).

How large is NEA Management Company, LLC's portfolio?

NEA Management Company, LLC reported $1.59B of long equity holdings across 26 positions as of 2026-Q2. Top-10 holdings account for 89.8% of reported value.

What is NEA Management Company, LLC's investment style?

HoldingsHub classifies the portfolio as Mid / Focused / Health Tilt, computed from size, concentration, sector tilt and turnover.

Where does this data come from?

All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.

Embed this fund on your site

Copy the snippet below to show this fund's live top holdings on your blog or forum — free, auto-updating, links back to HoldingsHub.

<iframe src="https://holdingshub.top/funds/nea-management/widget" width="100%" height="520" frameborder="0" loading="lazy" title="HoldingsHub fund holdings"></iframe>

Preview the embeddable widget →